- Previous Close
496.85 - Open
496.10 - Bid --
- Ask --
- Day's Range
476.00 - 501.85 - 52 Week Range
355.45 - 630.00 - Volume
18,677 - Avg. Volume
66,108 - Market Cap (intraday)
6.065B - Beta (5Y Monthly) 1.50
- PE Ratio (TTM)
82.94 - EPS (TTM)
5.74 - Earnings Date Feb 10, 2025 - Feb 14, 2025
- Forward Dividend & Yield 1.00 (0.22%)
- Ex-Dividend Date Sep 19, 2024
- 1y Target Est
--
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarial, vitamins and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.
www.medicamen.com378
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: MEDICAMEQ.NS
View MorePerformance Overview: MEDICAMEQ.NS
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MEDICAMEQ.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MEDICAMEQ.NS
View MoreValuation Measures
Market Cap
6.10B
Enterprise Value
6.24B
Trailing P/E
83.47
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.35
Price/Book (mrq)
2.82
Enterprise Value/Revenue
3.43
Enterprise Value/EBITDA
28.77
Financial Highlights
Profitability and Income Statement
Profit Margin
4.49%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
1.8B
Net Income Avi to Common (ttm)
81.05M
Diluted EPS (ttm)
5.74
Balance Sheet and Cash Flow
Total Cash (mrq)
147.86M
Total Debt/Equity (mrq)
15.37%
Levered Free Cash Flow (ttm)
--